BDD Pharma Opens Brand New GMP Manufacturing Facility Following £2m In Funding
The BDD facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The BDD facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes.
This raise reflects accelerating market conviction that healthcare advocacy is a critical standard of care that drives better outcomes, lowers costs, and enhances patient experiences notes Solace.
SHL Medical is significantly increasing its production capacity to meet growing demand in North America while strengthening supply chain resilience.